So Young Park1, Hyun Jung Kim1, Kwan Ha Yoo1, Yong Bum Park1, Seo Woo Kim1, Seok Jeong Lee1, Eun Kyung Kim1, Jung Hyun Kim1, Yee Hyung Kim1, Ji-Yong Moon1, Kyung Hoon Min1, Sung Soo Park1, Jinwoo Lee1, Chang-Hoon Lee1, Jinkyeong Park1, Min Kwang Byun1, Sei Won Lee1, ChinKook Rlee1, Ji Ye Jung1, Yun Su Sim1. 1. 1 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kandong Sacred Heart Hospital, Seoul, Korea ; 2 Institute for Evidence-based Medicine, The Korean Branch of Australasian Cochrane Center, Department of Preventive Medicine, College of Medicine, Korea University, Seoul, Korea ; 3 Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea ; 4 Department of Internal Medicine, Ewha Medical Center and Ewha Medical Research Institute, Ewha Womans University School of Medicine, Seoul, Korea ; 5 Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea ; 6 Department of Pulmonary and Critical Care Medicine, Kyung Hee University Hospital at Gangdong, School of Medicine, Kyung Hee University, 7 Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea ; 8 Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea ; 9 Department of Internal Medicine, Seoul National University Boramae Hospital, Seoul, Korea ; 10 Department of Pulmonary and Critical Care Medicine Wonkwang University, Sanbon Hospital, Sanbon, Korea ; 11 Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea ; 12 Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea ; 13 Department of Internal Medicine, College of Medicine, Catholic University of Korea, Seoul, Korea ; 14 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea.
Abstract
BACKGROUND: Prone positioning for acute respiratory distress syndrome (ARDS) has no impact on mortality despite significant improvements in oxygenation. However, a recent trial demonstrated reduced mortality rates in the prone position for severe ARDS. We evaluated effects of prone position duration and protective lung strategies on mortality rates in ARDS. METHODS: We extensively searched MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials to identify randomized controlled trials (RCTs) reporting on prone positioning during acute respiratory failure in adults for inclusion in our meta-analysis. RESULTS: Eight trials met our inclusion criteria, Totals of 1,099 and 1,042 patients were randomized to the prone and supine ventilation positions. The mortality rates associated with the prone and supine positions were 41% and 47% [risk ratio (RR), 0.90; 95% confidence interval (CI), 0.82-0.98, P=0.02], but the heterogeneity was moderate (P=0.01, I(2)=61%). In a subgroup analysis, the mortality rates for lung protective ventilation (RR 0.73, 95% CI, 0.62-0.86, P=0.0002) and duration of prone positioning >12 h (RR 0.75, 95% CI, 0.65-0.87, P<0.0001) were reduced in the prone position. Prone positioning was not associated with an increased incidence of cardiac events (RR 1.01, 95% CI, 0.87-1.17) or ventilator associated pneumonia (RR 0.88, 95% CI, 0.71-1.09), but it was associated with an increased incidence of pressure sores (RR 1.23, 95% CI, 1.07-1.41) and endotracheal dislocation (RR 1.33, 95% CI, 1.02-1.74). CONCLUSIONS: Prone positioning tends to reduce the mortality rates in ARDS patients, especially when used in conjunction with a lung protective strategy and longer prone position durations. Prone positioning for ARDS patients should be prioritized over other invasive procedures because related life-threatening complications are rare. However, further additional randomized controlled design to study are required for confirm benefit of prone position in ARDS.
BACKGROUND: Prone positioning for acute respiratory distress syndrome (ARDS) has no impact on mortality despite significant improvements in oxygenation. However, a recent trial demonstrated reduced mortality rates in the prone position for severe ARDS. We evaluated effects of prone position duration and protective lung strategies on mortality rates in ARDS. METHODS: We extensively searched MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials to identify randomized controlled trials (RCTs) reporting on prone positioning during acute respiratory failure in adults for inclusion in our meta-analysis. RESULTS: Eight trials met our inclusion criteria, Totals of 1,099 and 1,042 patients were randomized to the prone and supine ventilation positions. The mortality rates associated with the prone and supine positions were 41% and 47% [risk ratio (RR), 0.90; 95% confidence interval (CI), 0.82-0.98, P=0.02], but the heterogeneity was moderate (P=0.01, I(2)=61%). In a subgroup analysis, the mortality rates for lung protective ventilation (RR 0.73, 95% CI, 0.62-0.86, P=0.0002) and duration of prone positioning >12 h (RR 0.75, 95% CI, 0.65-0.87, P<0.0001) were reduced in the prone position. Prone positioning was not associated with an increased incidence of cardiac events (RR 1.01, 95% CI, 0.87-1.17) or ventilator associated pneumonia (RR 0.88, 95% CI, 0.71-1.09), but it was associated with an increased incidence of pressure sores (RR 1.23, 95% CI, 1.07-1.41) and endotracheal dislocation (RR 1.33, 95% CI, 1.02-1.74). CONCLUSIONS: Prone positioning tends to reduce the mortality rates in ARDS patients, especially when used in conjunction with a lung protective strategy and longer prone position durations. Prone positioning for ARDS patients should be prioritized over other invasive procedures because related life-threatening complications are rare. However, further additional randomized controlled design to study are required for confirm benefit of prone position in ARDS.
Authors: Euan A Ashley; Attila Kardos; Ewan S Jack; Walter Habenbacher; Mathew Wheeler; Young M Kim; Jeffrey Froning; Jonathan Myers; Gregory Whyte; Victor Froelicher; Pamela Douglas Journal: J Am Coll Cardiol Date: 2006-07-12 Impact factor: 24.094
Authors: G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg Journal: Am J Respir Crit Care Med Date: 1994-03 Impact factor: 21.405
Authors: Martha A Q Curley; Patricia L Hibberd; Lori D Fineman; David Wypij; Mei-Chiung Shih; John E Thompson; Mary Jo C Grant; Frederick E Barr; Natalie Z Cvijanovich; Lauren Sorce; Peter M Luckett; Michael A Matthay; John H Arnold Journal: JAMA Date: 2005-07-13 Impact factor: 56.272
Authors: Sachin Sud; Jan O Friedrich; Paolo Taccone; Federico Polli; Neill K J Adhikari; Roberto Latini; Antonio Pesenti; Claude Guérin; Jordi Mancebo; Martha A Q Curley; Rafael Fernandez; Ming-Cheng Chan; Pascal Beuret; Gregor Voggenreiter; Maneesh Sud; Gianni Tognoni; Luciano Gattinoni Journal: Intensive Care Med Date: 2010-02-04 Impact factor: 17.440
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Frank Dodoo-Schittko; Susanne Brandstetter; Magdalena Brandl; Sebastian Blecha; Michael Quintel; Steffen Weber-Carstens; Stefan Kluge; Patrick Meybohm; Caroline Rolfes; Björn Ellger; Friedhelm Bach; Tobias Welte; Thomas Muders; Kathrin Thomann-Hackner; Thomas Bein; Christian Apfelbacher Journal: J Thorac Dis Date: 2017-03 Impact factor: 2.895